See also this year's filing and all EDGAR filings for this company.
PDF Report 0000792977_2012_AMAG_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments'} |
Graph
Absolute values for 0000792977, AMAG Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 240,031,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 9,206,000 |
| 3 | remainder_Assets | 17,987,000 |
| 4 | LiabilitiesCurrent | 38,994,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 47,634,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 68,863,000 |
| 9 | ResearchAndDevelopmentExpense | 58,140,000 |
| 10 | remainder_Expenses | 14,039,000 |
| 11 | remainder_Revenues | 61,249,000 |
| 12 | remainder_NetIncome | 1,554,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 267,224,000 |
| 1 | Liabilities | 86,628,000 |
| 2 | Expenses | 141,042,000 |
| 3 | Revenues | 61,249,000 |
| 4 | StockholdersEquity | 180,596,000 |
| 5 | NetIncome | -78,239,000 |
| 6 | ComprehensiveNetIncome | -78,239,000 |
| 7 | BaseVar | 278,848,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.78 |
| 9 | EconomicCapitalRatio | 2.88 |
Edgar->Model Mapping
Feature Distribution
Change over Time
